Vaxart

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.28-$1.07
Market Cap
$78.4M
Shares Short
12M

Financials

See more
Revenue (12 Mos)
$28.7M
Revenue Growth (YoY)
368%
Gross Profit (12 Mos)
-$45.5M
Diluted EPS
-$0.33

News

See more

Yahoo Finance • last month

Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

Yahoo Finance • last month

Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

Yahoo Finance • last month

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

Yahoo Finance • 2 months ago

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

About

CEO
Mr. Steven Lo
CFO
Mr. Phillip Eric Lee
Address
170 Harbor Way, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
105